Vasodilator actions of abnormal-cannabidiol in rat isolated small mesenteric artery (full - 2003)http://www.ncbi.nlm.nih.gov/pmc/arti...tool=pmcentrez
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor (full – 2003)http://molpharm.aspetjournals.org/content/63/3/699.long
2-Arachidonylglyceryl ether and abnormal cannabidiol-induced vascular smooth muscle relaxation in rabbit pulmonary arteries via receptor-pertussis toxin sensitive G proteins-ERK1/2 signaling (abst – 2007) http://www.ncbi.nlm.nih.gov/pubmed/17292352
Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery (abst – 2007)http://www.ncbi.nlm.nih.gov/pubmed/17921818
Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2 (full – 2008) http://molpharm.aspetjournals.org/content/73/2/441.long
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (full – 2010)http://pharmrev.aspetjournals.org/co....full.pdf+html
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor (full – 2010) http://www.biomedcentral.com/1471-2202/11/44
Nonpsychotropic Cannabinoids, Abnormal Cannabidiol and Canabigerol-Dimethyl Heptyl, Act at Novel Cannabinoid Receptors to Reduce Intraocular Pressure (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21770780
The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55 (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21683763
siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl glycine-induced cell migration (full – 2012)http://www.jmolecularsignaling.com/content/7/1/10
GPR18 in microglia: implications for the CNS and endocannabinoid system signaling (full – 2012)http://onlinelibrary.wiley.com/doi/1...2.02019.x/full
Involvement of a non-CB1/CB2 cannabinoid receptor in the aqueous humor outflow-enhancing effects of abnormal-cannabidiol (abst – 2012)http://www.ncbi.nlm.nih.gov/pubmed/22580290
A GPR18-based signaling system regulates IOP in murine eye (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687663/
Mechanism of Central Atypical Cannabinoid Receptor GPR18-Mediated Hypotension in Conscious Rats (abst – 2013)http://www.fasebj.org/cgi/content/me...c-38c0c63c19ad
Role of Central Atypical Cannabinoid Receptor GPR18 in Modulating Cardiovascular Function (abst – 2013)http://www.fasebj.org/cgi/content/me...c-38c0c63c19ad
Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23992544
Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24030360
Neuronal Nitric Oxide Synthase Dependent Elevation in Adiponectin in the Rostral Ventrolateral Medulla Underlies GPR18-mediated Hypotension in Conscious Rats (full – 2014) http://jpet.aspetjournals.org/conten...14.216036.long
The Novel Endocannabinoid Receptor GPR18 is Expressed in the Rostral Ventrolateral Medulla and Exerts Tonic Restraining Influence on Blood Pressure (full – 2014) http://jpet.aspetjournals.org/conten...13.209213.long
Vascular targets for cannabinoids: animal and human studies (full – 2014) http://onlinelibrary.wiley.com/doi/1...bph.12560/full
Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24751709
Activation of GPR18 by Cannabinoid compounds: A tale of biased agonism. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24762058
Selective ligands and cellular effectors of a G protein-coupled endothelial cannabinoid receptor (full – 2003)http://molpharm.aspetjournals.org/content/63/3/699.long
2-Arachidonylglyceryl ether and abnormal cannabidiol-induced vascular smooth muscle relaxation in rabbit pulmonary arteries via receptor-pertussis toxin sensitive G proteins-ERK1/2 signaling (abst – 2007) http://www.ncbi.nlm.nih.gov/pubmed/17292352
Identification of the vasodilatory endothelial cannabinoid receptor in the human pulmonary artery (abst – 2007)http://www.ncbi.nlm.nih.gov/pubmed/17921818
Inhibition of human neutrophil chemotaxis by endogenous cannabinoids and phytocannabinoids: evidence for a site distinct from CB1 and CB2 (full – 2008) http://molpharm.aspetjournals.org/content/73/2/441.long
International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid Receptors and Their Ligands: Beyond CB1 and CB2 (full – 2010)http://pharmrev.aspetjournals.org/co....full.pdf+html
N-arachidonoyl glycine, an abundant endogenous lipid, potently drives directed cellular migration through GPR18, the putative abnormal cannabidiol receptor (full – 2010) http://www.biomedcentral.com/1471-2202/11/44
Nonpsychotropic Cannabinoids, Abnormal Cannabidiol and Canabigerol-Dimethyl Heptyl, Act at Novel Cannabinoid Receptors to Reduce Intraocular Pressure (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21770780
The abnormal cannabidiol analogue O-1602 reduces nociception in a rat model of acute arthritis via the putative cannabinoid receptor GPR55 (abst – 2011) http://www.ncbi.nlm.nih.gov/pubmed/21683763
siRNA knockdown of GPR18 receptors in BV-2 microglia attenuates N-arachidonoyl glycine-induced cell migration (full – 2012)http://www.jmolecularsignaling.com/content/7/1/10
GPR18 in microglia: implications for the CNS and endocannabinoid system signaling (full – 2012)http://onlinelibrary.wiley.com/doi/1...2.02019.x/full
Involvement of a non-CB1/CB2 cannabinoid receptor in the aqueous humor outflow-enhancing effects of abnormal-cannabidiol (abst – 2012)http://www.ncbi.nlm.nih.gov/pubmed/22580290
A GPR18-based signaling system regulates IOP in murine eye (full – 2013) http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3687663/
Mechanism of Central Atypical Cannabinoid Receptor GPR18-Mediated Hypotension in Conscious Rats (abst – 2013)http://www.fasebj.org/cgi/content/me...c-38c0c63c19ad
Role of Central Atypical Cannabinoid Receptor GPR18 in Modulating Cardiovascular Function (abst – 2013)http://www.fasebj.org/cgi/content/me...c-38c0c63c19ad
Evaluation of the insulin releasing and antihyperglycaemic activities of GPR55 lipid agonists using clonal beta-cells, isolated pancreatic islets and mice (abst – 2013) http://www.ncbi.nlm.nih.gov/pubmed/23992544
Cannabinoid Effects on β Amyloid Fibril and Aggregate Formation, Neuronal and Microglial-Activated Neurotoxicity In Vitro (abst – 2013)http://www.ncbi.nlm.nih.gov/pubmed/24030360
Neuronal Nitric Oxide Synthase Dependent Elevation in Adiponectin in the Rostral Ventrolateral Medulla Underlies GPR18-mediated Hypotension in Conscious Rats (full – 2014) http://jpet.aspetjournals.org/conten...14.216036.long
The Novel Endocannabinoid Receptor GPR18 is Expressed in the Rostral Ventrolateral Medulla and Exerts Tonic Restraining Influence on Blood Pressure (full – 2014) http://jpet.aspetjournals.org/conten...13.209213.long
Vascular targets for cannabinoids: animal and human studies (full – 2014) http://onlinelibrary.wiley.com/doi/1...bph.12560/full
Cannabinoid and lipid-mediated vasorelaxation in retinal microvasculature. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24751709
Activation of GPR18 by Cannabinoid compounds: A tale of biased agonism. (abst – 2014) http://www.ncbi.nlm.nih.gov/pubmed/24762058